09 Feb 2025
More possibilities in TEER - Treatment of degenerative mitral regurgitation
Sponsored by Edwards Lifesciences
Anchorperson:
K. Hayashida
Summary
Through case reviews, explore the latest advancements in transcatheter edge-to-edge repair (TEER) for degenerative mitral regurgitation. Discover how a novel TEER device expands treatment possibilities, offering predictable and durable results.
Learning Objectives
- To understand how a novel TEER device provides more possibilities in TEER for degenerative mitral regurgitation
- To develop understanding of predictable and durable treatment of mitral regurgitation
- To review the clinical evidence strategy and become acquainted with the most current data available
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide016.jpg)
/slide017.jpg)
/slide018.jpg)
/slide019.jpg)
/slide020.jpg)
/slide021.jpg)
/slide022.jpg)
/slide023.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)